The aim of the present study however was to assess the independent prognostic value of PSMA expression on prostate biopsy specimens enabling a future PSMA based risk stratification of PCa patients with localized disease at time of initial diagnosis. This evidence concerns the gene FOLH1 and posterior cortical atrophy.